surmount-1 trial tirzepatide obesity without diabetes weight loss (ZEPBOUND) Approved for Chronic Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or In the SURMOUNT-1 trial (published

We serve patients from Frederick MD, Mt Pleasant MD, Braddock Heights MD, Walkersville MD, Lewistown MD, Urbana MD, Ballenger Creek MD, and surrounding areas

[2] [3] [4] Warn patients about the potential for somnolence, dizziness, confusion, difficulty concentrating, or visual effects, and advise patients against driving or operating machinery until they have gained sufficient experience on topiramate to gauge whether it adversely affects their mental performance, motor performance, and/or vision

Avoid rapid injections and high-speed plunges

If you are on thyroid hormone medication, prior to starting Tirzepatide , please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted

The physical changes did come, but that wasnt the most profound part of the journey